Form D · Biotechnology
Gregor Diagnostics, Inc.
Dallas, TX · CIK 0001746381
Offering snapshot reported Nov 4, 2025 · SEC filing
- Reported sold
- $242K Offering amount: $250K
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 20, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 4, 2025 | Initial | $242,034 | No comparison | 13 | SEC filing |
| Dec 16, 2024 | Amendment | $7,429,000 | $3,032,000vs Oct 31, 2023 | 8 | SEC filing |
| Oct 31, 2023 | Initial | $4,397,000 | No comparison | 4 | SEC filing |
| Oct 29, 2021 | Initial | $5,039,710 | No comparison | 7 | SEC filing |
| Oct 28, 2019 | Initial | $915,667 | No comparison | 8 | SEC filing |
| Jul 12, 2018 | Initial | $900,000 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-563023
Source: Form D, filed Nov 4, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sundaresh Brahmasandra | Director |
| Mike Bress | Executive |
| Gilbert G Garcia | Director |
| Michael Partsch | Director |
| Lauren Tyra | Director |
| Steven Weinstein | Director |
| Tobias Zutz | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5910 N. Central Expressway Suite 1400
Dallas, TX, 75206
Dallas, TX, 75206